| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |